{"name":"Sesen Bio, Inc.","slug":"sesen-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Proxinium","genericName":"Proxinium","slug":"proxinium","indication":"Other","status":"discontinued"},{"name":"Vicinium","genericName":"Vicinium","slug":"vicinium","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Proxinium","genericName":"Proxinium","slug":"proxinium","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vicinium","genericName":"Vicinium","slug":"vicinium","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE0tdlIyOWVBVzhaVzZVTTZmS1lFd1d3UUZsQUs2eUlwTkViZkZtMnN2cC1kb2VnQVo2c1JIVzlhUjB2SXdMS2VkQ0psMA?oc=5","date":"2026-04-03","type":"pipeline","source":"Meyka","summary":"Sesen Bio, Inc. (SESN) Competitors - Meyka","headline":"Sesen Bio, Inc. (SESN) Competitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOcnZmRmFaMzg3c2RmNmFyV0xLT0RoX2VTc0dDc09mNnZORmxZb3dQMnRmeXJNT0k2YS04cHdIeHRQd0dwNnRXWXFaeVdxRlB0d1BwVVE5dzlrUDZLcFhfem5KS2IxT3JDQllKUmZvYVk2azR1UVk0dDZlU3JLZ21lbnkzLUliTmk2bFJFUUZJUVZTMDJlNk1TNjNxWGNLQzVIQkZlZUdyY3gwMHNFZjhsTDRkMnFuYWpvVnBlS2VYTUFZUQ?oc=5","date":"2025-03-20","type":"pipeline","source":"Fierce Pharma","summary":"Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover - Fierce Pharma","headline":"Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbnVwb1V3ZUNoc1pkTWJPRHI1N3FXbnNSNDB5NGlrQTRCUUVocmxNNENETTB5Vm5NLXhzangyM1RvbFI1aTVLZ1E4cUdMN3pvOTFidDM0ZFdha2dzRzF0SUZBQW15OW92MUlqbDZVVkV4T3VUOTdTOS1FUUZpQlhTaUhzRXROTjNUcXhLNzdDVGVhckdFbzRNVzRjcFc4M2oyYWFxYjNXLXQ?oc=5","date":"2023-03-07","type":"deal","source":"prnewswire.com","summary":"Carisma Therapeutics Closes Merger with Sesen Bio - prnewswire.com","headline":"Carisma Therapeutics Closes Merger with Sesen Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPWk5ZLTVXYjVkWmt6aUxRV0RMTFRld2hlQVZzRndyT3JzSVNxMHgwSlpYRnZ6bUhQSy1kcVk1bEtub09TR2xBcTJ4a1pQajI3RDcwV3JhcXBYbTg5aDZUcERNVlNTYnlEOWVQQUFUN3NncUxQVlpES2FrcTYybnExOS02bnc0X3p4Xy1GcG0xYmw2Z3d5R25PYmh4aDBMeGhYV1ZObWd5M2hwLWtGMVRYNVc3VUxJcjYwdjBEeQ?oc=5","date":"2023-03-02","type":"regulatory","source":"Business Wire","summary":"Sesen Bio Stockholders Approve Merger with Carisma Therapeutics - Business Wire","headline":"Sesen Bio Stockholders Approve Merger with Carisma Therapeutics","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5QSnhVbkdfWnl2Ti1ua2JXY056UXJ6MmE3VDl2Y2FwZW16dHpkUFdwTFg1Yk9RWktXa2tsZzZKREYyS2hkcjF5MXlXazBzNVpublNjUENnUFlRUndERmZ6dnFXUm5DbzBlbEE?oc=5","date":"2022-11-06","type":"pipeline","source":"GuruFocus","summary":"Sanford S Zweifach Net Worth (2026) - GuruFocus","headline":"Sanford S Zweifach Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPcV9PTG5RSzJQaHFWT0FabjlmekhpNXViSEZ0YUZnMEhrRHBfZHppZTYxM19NaGV3NGVPdi1sU0NPblZiU3hTSHV3X1I1VDEzcjFIR3RWRGlWYUZ2R3k1SHFGZnA5cU9RQXNCU3JyTnZtZk1pTS1OOXNjMDBWV09QMGs1UGdZUFpfVDJ2bg?oc=5","date":"2022-09-21","type":"pipeline","source":"BioPharma Dive","summary":"Cell therapy startup Carisma merges with troubled Sesen in bid for Wall Street - BioPharma Dive","headline":"Cell therapy startup Carisma merges with troubled Sesen in bid for Wall Street","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPSWMxaDRIWjlzMEdPbTRTNE9NMnJ2R2d6a3htMmxjTWdyZjd3Wmc1d3hxZW9abzZpbFJia2xFTmNrR2ZoZUNRLXJGZC1yUjI1UThwcW1ISGY1S2VmSl9POTF6ZDhjaWxuMTJzb0dOS09IOEp6WDRRTEpZdXlWbjI3SkFGVGktUTN4N284dUo1YkcxR3pMclln?oc=5","date":"2022-05-05","type":"deal","source":"PennyStocks.com","summary":"10 Top Penny Stocks To Buy For Under $1 May 2022 Edition - PennyStocks.com","headline":"10 Top Penny Stocks To Buy For Under $1 May 2022 Edition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQUy1mb01IanN4ZllaTjVYbkFsU21UNFdlTlNXVVNWdjcwdGFVMFRNaVFlN3UwUTF0aEJsTGxzZnNQc2pMbG5uaXpJZG9wMXlfRnJXMmFUNEhsVmVPa2djaXZmM2VvWWtQanVjNlhvSWRyUEROT3NKRGN5UXU2My16V21pNEpBVUR6R2pBR1dKWTMxQzFsbjc0R2p0ZVZqUjE1QlBhN0c2YmpVcmRKRWJjV0R4TDVMc28?oc=5","date":"2021-11-29","type":"pipeline","source":"citybiz","summary":"Sesen Bio Appoints Dominika Kowalski as Senior Director of Global Drug Safety - citybiz","headline":"Sesen Bio Appoints Dominika Kowalski as Senior Director of Global Drug Safety","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOT2pHbWZ1ekFEZ29QQWRNNW9WbkRpeUZZYnNKWTk1ZkpMOGJYaUU3VDVIdFoza1l0VDRmQkIxZG92UXh3aDJXSXJHZXlxZk1HM2xMRUtuLWM0bXRhdi1RazNaMjFOSVBxeXJMc1FCRVNaY2VTdV8xV3JFVi13R2tYWTItZDljdjdHVW82MExKNW5WcFMwQlBaWXc5OWh2SDFVLXZPZDQwWHBOWnJnZGQ5NFRrNzlUUVFhR0ZIOE96Qi12Vm11U3NyS2tqSQ?oc=5","date":"2021-08-13","type":"regulatory","source":"Reuters","summary":"U.S. FDA declines to approve Sesen Bio's bladder cancer treatment, shares plunge - Reuters","headline":"U.S. FDA declines to approve Sesen Bio's bladder cancer treatment, shares plunge","sentiment":"positive"}],"patents":[],"drugCount":2,"phaseCounts":{"discontinued":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}